Home » New J&J CEO Zeroes in on Recalls
New J&J CEO Zeroes in on Recalls
Alex Gorsky, Johnson & Johnson’s incoming chief executive, said his no. 1 priority is fixing the problems in the company’s OTC medicine business following recent recalls that have dimmed sales and damaged the health-care giant’s reputation.
The Wall Street Journal
The Wall Street Journal
Upcoming Events
-
07May
-
14May
-
30May